z-logo
open-access-imgOpen Access
A proof-of-concept clinical study examining the NRF2 activator sulforaphane against neutrophilic airway inflammation
Author(s) -
Charity Duran,
Allison J. Burbank,
Kingston H. G. Mills,
Heather Duckworth,
Maria M. Aleman,
Matthew J. Kesic,
David B. Peden,
Yinghao Pan,
Haibo Zhou,
Michelle Hernández
Publication year - 2016
Publication title -
carolina digital repository (university of north carolina at chapel hill)
Language(s) - English
DOI - 10.17615/11jf-dt18
Subject(s) - sulforaphane , inflammation , proof of concept , activator (genetics) , immunology , chemistry , medicine , biochemistry , computer science , operating system , gene

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here